Why Can't Children Use Methotrexate Like Adults?
Children often can't use methotrexate in the same way as adults due to differences in dosing, safety profiles, and approved formulations. The drug requires precise weight- or body surface area-based calculations to avoid toxicity, and pediatric patients face higher risks from immature liver and kidney function, which slow drug clearance.[1] Standard adult tablets (often 2.5 mg) are impractical for kids needing micro-doses as low as 2.5-7.5 mg weekly for conditions like juvenile idiopathic arthritis (JIA).[2]
What Doses Are Safe for Kids?
Pediatric methotrexate starts at 10-15 mg/m2 body surface area weekly, far lower than adult rheumatoid arthritis doses of 7.5-25 mg flat weekly.[3] Overdosing risks severe side effects like bone marrow suppression or mucositis. Liquid formulations (1 mg/mL solution) or subcutaneous injections allow accurate low dosing unavailable in adult pills.[4]
Which Forms Are Approved for Children?
Oral tablets aren't FDA-approved below age 2-3 due to swallowing risks and imprecise dosing. Instead:
- Rasuvo (auto-injector, 7.5-25 mg/0.4-1.5 mL) is approved for JIA in patients 2+ years.[5]
- Otrexup (similar auto-injector) for polyarticular JIA ages 2+.[6]
High-dose IV methotrexate is used in pediatric oncology (e.g., leukemia) with folinic acid rescue, but not for adult-style low-dose therapy.[7]
What Side Effects Hit Kids Harder?
Kids experience more nausea, vomiting, alopecia, and infections from weaker immune responses. Long-term, growth stunting and liver fibrosis risks are elevated, requiring frequent monitoring (blood tests every 1-3 months).[8][9] Adults tolerate higher cumulative doses better due to mature physiology.
How Does It Compare to Adult Use?
| Aspect | Adults | Children |
|--------|--------|----------|
| Common Dose | 7.5-25 mg/week oral | 10-15 mg/m²/week (often injectable) |
| Form | Tablets, injections | Mostly liquids/injectors |
| Monitoring | Every 1-3 months | Monthly, with growth checks |
| Indications | RA, psoriasis | JIA, ALL (high-dose) |
When Is It Used Off-Label or Experimentally in Kids?
For eczema or lupus, low-dose oral methotrexate is sometimes used off-label ages 3+, but guidelines stress injectables to minimize GI upset.[10] Ongoing trials explore optimized pediatric formulations.
Sources
[1] NCBI StatPearls: Methotrexate
[2] Arthritis Foundation: Pediatric MTX Dosing
[3] FDA Methotrexate Label
[4] Rasuvo.com (Medac Pharma)
[5] FDA Rasuvo Label
[6] FDA Otrexup Label
[7] NCI: Methotrexate in Pediatric Cancer
[8] AAP: MTX in JIA
[9] Pediatr Rheumatol: Pediatric MTX Safety
[10] AAD: MTX for Pediatric Eczema